| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/11/2004 | CA2218358C Human embryonic lung fibroblast diploid cell strain suitable for the production of virus and process for the production of varicella zoster virus using same |
| 05/11/2004 | CA2045950C Recombinant vaccine for prevention and/or treatment of pleuropneumonia infections |
| 05/07/2004 | CA2448481A1 A cell therapy method for the treatment of tumors |
| 05/06/2004 | WO2004038375A2 Water soluble toxin produced by pfiesteria species |
| 05/06/2004 | WO2004038024A1 Recombinant mva strains as potential vaccines against p. falciparum malaria |
| 05/06/2004 | WO2004038003A2 Human polypeptides encoded by polynucleotides and methods of their use |
| 05/06/2004 | WO2004037997A2 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof |
| 05/06/2004 | WO2004037972A2 Endogenous retrovirus up-regulated in prostate cancer |
| 05/06/2004 | WO2004037856A2 Plasmodium falciparum virulence factor var o |
| 05/06/2004 | WO2004037854A1 Prion protein-binding peptide sequences |
| 05/06/2004 | WO2004037847A2 Hiv envelope-cd4 complexes and hybrids |
| 05/06/2004 | WO2004037846A1 Immunisation against components of the human immunodeficiency virus (hiv) |
| 05/06/2004 | WO2004037286A2 Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof |
| 05/06/2004 | WO2004037285A1 Epicutaneous immunisation system |
| 05/06/2004 | WO2004037284A1 Anti-cancer vaccines and high-dose cytokines as adjuvants |
| 05/06/2004 | WO2004037205A2 LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNFα ACTIVITY IS DETRIMENTAL |
| 05/06/2004 | WO2004037198A2 Antibody-mediated induction of tumor cell death |
| 05/06/2004 | WO2004037192A2 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases |
| 05/06/2004 | WO2004037189A2 Methods for vaccinating against malaria |
| 05/06/2004 | WO2004037182A2 Active specific immunotherapy of cancer metastasis |
| 05/06/2004 | WO2004037175A2 Compositions and methods for treating human papillomavirus-mediated disease |
| 05/06/2004 | WO2004030696A3 Composition for vaccination |
| 05/06/2004 | WO2004021992A9 Delivery of therapeutics to the brain and spinal cord |
| 05/06/2004 | WO2004019976A3 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 05/06/2004 | WO2004014953A3 Anti-myelin associated glycoprotein (mag) antibodies |
| 05/06/2004 | WO2004013629A3 Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
| 05/06/2004 | WO2004004761A3 Adjuvant viral particle |
| 05/06/2004 | WO2004004750A3 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 05/06/2004 | WO2003105891A3 Use of hec1 antagonists in the treatment of proliferative disorders and cancer |
| 05/06/2004 | WO2003103570A9 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles |
| 05/06/2004 | WO2003103389A3 Cryopreservation of haptenized tumor cells |
| 05/06/2004 | WO2003073828B1 Immunotherapy for prostate cancer using recombinant bacille calmette-guerin expressing prostate specific antigens |
| 05/06/2004 | WO2003062407A8 INFECTIOUS cDNA CLONES OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EXPRESSION VECTORS THEREOF |
| 05/06/2004 | WO2003054176A3 Preparation of vaccines using photosensitizer and light |
| 05/06/2004 | WO2003050502A9 Prospective identification and characterization of breast cancer stem cells |
| 05/06/2004 | WO2003048186B1 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 05/06/2004 | WO2003046008A9 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma |
| 05/06/2004 | WO2003045316A9 Polynucleotide therapy |
| 05/06/2004 | WO2003026578A9 Pine cone extracts and uses thereof |
| 05/06/2004 | WO2003025019A9 Anti-pdgf antibodies and methods for producing engineered antibodies |
| 05/06/2004 | WO2003022298A3 Use of a protein of the crmp family for treating diseases related to the immune system |
| 05/06/2004 | WO2003011903A3 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 05/06/2004 | WO2003009817A9 Stable lyophilized pharmaceutical formulation of igg antibodies |
| 05/06/2004 | WO2002098456A3 Antigens and vectors for vaccination |
| 05/06/2004 | WO2002092788A9 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 05/06/2004 | WO2002074251A9 Monoclonal antibody therapy for pancreas cancer |
| 05/06/2004 | WO2002061113A9 Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation |
| 05/06/2004 | WO2001074296A3 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists |
| 05/06/2004 | US20040088765 Animal immunocontraceptives expressed in plants and uses thereof |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040087777 Humanized antibodies that recognize beta amyloid peptide |
| 05/06/2004 | US20040087772 Tumor marker polypeptide for diagnosis, prevention and treatment of cell proliferative disorders; antitumor/anticarcinogenic agents |
| 05/06/2004 | US20040087770 Viral peptide for use in diagnosing, preventing and treating sepsis and meningitis; microbiocides; vaccine development |
| 05/06/2004 | US20040087607 Adjust intensity of analgesics; blocking gangliosides |
| 05/06/2004 | US20040087555 Phosphohalohydrins, process for the production thereof and use thereof |
| 05/06/2004 | US20040087538 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 05/06/2004 | US20040087534 2-100 nucleotides containing >/= 1 unmethylated cytosine-guanine dinucleotide; antisense therapies; in vivo hybridization probes; viricides |
| 05/06/2004 | US20040087532 Vaccine comprising antigen presenting cells loaded with at least two tumor antigens and/or tumor antigen derived peptides |
| 05/06/2004 | US20040087529 Delivery system for entrapping charged macromolecules and a method for preparing same |
| 05/06/2004 | US20040087521 Nucleic acid pharmaceuticals-influenza matrix |
| 05/06/2004 | US20040087481 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 05/06/2004 | US20040087020 Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin |
| 05/06/2004 | US20040087002 Using attenuated viral sequence to develop vaccines to prevent porcine reproductive and respiratory syndrome in swine; immunotherapy |
| 05/06/2004 | US20040087001 Transgenic viral particles to enhance cell fusion and transfer genetic material into polymorphonuclear leukocytes (PMNL); gene therapy |
| 05/06/2004 | US20040086977 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 05/06/2004 | US20040086976 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 05/06/2004 | US20040086949 Solid phase synthesis; immunology; vaccines; for generating antibodies; kits |
| 05/06/2004 | US20040086910 Comprises nucleotide sequences coding tumor antigen-derived gene (TADG-15) protein for diagnosis, prevention and treatment of breast and ovarian cancers |
| 05/06/2004 | US20040086863 Comprises pleckstrin homology domain-interacting protein (PHI Protein) for identifying modulator and treatment for cancer and insulin response disorders |
| 05/06/2004 | US20040086846 Using bacterial artificial chromosomes to propagate/replicate viral nucleotide sequences; gene therapy and genetic vaccines |
| 05/06/2004 | US20040086845 Nucleotide sequences coding fusion protein comprising translocation domain for targeting and treating tumors; antitumor agents |
| 05/06/2004 | US20040086530 Transgenic plant or plant cell that, when consumed as a foodstuff in four or less feedings, elicits an anti-HBsAg boosting immune response that increases serum anti-HBsAg antibody levels at least four-fold |
| 05/06/2004 | US20040086529 Vaccines containing ribavirin and methods of use thereof |
| 05/06/2004 | US20040086527 Vaccine for conferring protection against human papillomavirus (HPV) infection in a human |
| 05/06/2004 | US20040086525 Polynucleotide sequences of C. pneumoniae for use in preventing and treating Chlamydia infection |
| 05/06/2004 | US20040086524 Vaccines and agents for inducing immunity in fish against rickettsial diseases, and associated preventative therapy |
| 05/06/2004 | US20040086523 Fusion proteins of mycobacterium tuberculosis |
| 05/06/2004 | US20040086522 Strategies to prevent autoimmune disease by vaccination with vaccines based upon Epstein-Barr virus |
| 05/06/2004 | US20040086521 Method for the identification of antigenic peptides |
| 05/06/2004 | US20040086520 CTL epitope analogs |
| 05/06/2004 | US20040086518 Universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 05/06/2004 | US20040086517 Porous, implantable device containing a fibrous support and at least one antigen |
| 05/06/2004 | US20040086516 Inhibiting antigen presentation, comprising the step of supplying to an antigen-presenting cell, such as a dendritic cell, or precursor cell, a modulator, preferably an enhancer, of Toll-related receptor signalling |
| 05/06/2004 | US20040086514 Based on the finding of a specific Helicobacter pylori receptor in the human gastric epithelium; a glycolipid, lactotetraosylceramide, exclusively found in the human gastrointestinal tract |
| 05/06/2004 | US20040086512 Multimerization of HIV-1 VIF protein as a therapeutic target |
| 05/06/2004 | US20040086508 Administering to the patient an effective amount of an antibody that specifically binds interferon gamma and an antibody that specifically binds tumor necrosis factor alpha |
| 05/06/2004 | US20040086506 Polyvalent immunogen |
| 05/06/2004 | US20040086503 High-affinity human anti-IGF-IR antibodies that could be used to treat diseases in humans |
| 05/06/2004 | US20040086502 Has a binding affinity for a target antigen which is at least about two fold stronger than the binding affinity of the parent antibody for said antigen |
| 05/06/2004 | US20040086500 Murabutide, an analog of muramyl dipeptide, induces the production of cytokines or other factors not identified to date, which have a suppressor activity on HIV |
| 05/06/2004 | US20040086485 Viral vector sequences in plasmid form delivered in-vivo to generate vector producing cells |
| 05/06/2004 | US20040086483 Pharmaceutical compositions and method for treating rheumathoid arthritis |
| 05/06/2004 | EP1416279A1 Methods for diagnosis and therapy of pancreatic cancer and composition useful therein |
| 05/06/2004 | EP1415665A2 BHV5 mutants |
| 05/06/2004 | EP1415659A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/06/2004 | EP1415005A2 Endogenous retroviruses up-regulated in prostate cancer |
| 05/06/2004 | EP1414994A2 Microorganisms and cells for diagnosis and therapy of tumors |
| 05/06/2004 | EP1414967A2 Gene associated with leishmania parasite virulence |
| 05/06/2004 | EP1414964A2 Vegf isoform |
| 05/06/2004 | EP1414948A2 Inhibition of apoptosis process and improvement of cell performance |